Skip to content

WORLD HEALTH ENERGY HOLDINGS, INC.: 10-Q filed 2022-11-21

What WORLD HEALTH ENERGY HOLDINGS, INC. reported in its quarterly report filed 2022-11-21 (fiscal Q3 2022): 30 published measures, 89 facts as tagged in accession 0001493152-22-033065.

This filing

Form
10-Q (quarterly report)
Filed
2022-11-21
Fiscal period
fiscal Q3 2022
Accession
0001493152-22-033065 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All WORLD HEALTH ENERGY HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-305,472,583USD
At 2021-12-311,588,375USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-302,830,399USD
At 2021-12-313,107,629USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-302,642,184USD
At 2022-06-30-1,268,160USD
At 2022-03-31-1,271,811USD
At 2021-12-31-1,519,254USD
At 2021-09-30-3,026,670USD
At 2021-06-30-2,455,542USD
At 2021-03-31-2,248,653USD
At 2020-12-31-1,982,562USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-09-30111,436USD
At 2021-12-3146,022USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-4,779,722USD92
2022-01-01 to 2022-09-30-9,158,022USD273
2022-04-01 to 2022-06-30-2,741,504USD91
2022-01-01 to 2022-03-31-1,636,796USD90
2021-07-01 to 2021-09-30-2,032,470USD92
2021-01-01 to 2021-09-30-2,505,450USD273
2021-04-01 to 2021-06-30-206,889USD91
2021-01-01 to 2021-03-31-266,091USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-818,346USD273
2021-01-01 to 2021-09-30-678,360USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-09-3017,798USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2022-07-01 to 2022-09-3023,726USD92
2022-01-01 to 2022-09-3067,480USD273
2021-07-01 to 2021-09-3033,717USD92
2021-01-01 to 2021-09-30115,167USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-09-30901,250USD273
2021-01-01 to 2021-09-30382,345USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-17,490USD273
2021-01-01 to 2021-09-30-10,565USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-30-15,251,472USD
At 2021-12-31-6,093,450USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-07-01 to 2022-09-30501,589,697,852shares92
2022-01-01 to 2022-09-30494,351,349,388shares273
2021-07-01 to 2021-09-3090,007,886,257shares92
2021-01-01 to 2021-09-3089,863,034,370shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-07-01 to 2022-09-300USD/shares92
2022-01-01 to 2022-09-300USD/shares273
2021-07-01 to 2021-09-300USD/shares92
2021-01-01 to 2021-09-300USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-09-3037,545USD
At 2021-12-3127,777USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-07-01 to 2022-09-304,529,664USD92
2022-01-01 to 2022-09-308,474,989USD273
2021-07-01 to 2021-09-301,459,120USD92
2021-01-01 to 2021-09-301,459,120USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-4,724,336USD92
2022-01-01 to 2022-09-30-9,139,270USD273
2021-07-01 to 2021-09-30-2,012,951USD92
2021-01-01 to 2021-09-30-2,455,015USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-09-30371,280USD
At 2021-12-311,312,175USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-30539,617USD
At 2021-12-31764,203USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-09-3091,038USD
At 2021-12-3180,059USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-09-3020,158USD
At 2021-12-3110,022USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-07-01 to 2022-09-30111,570USD92
2022-01-01 to 2022-09-30354,593USD273
2021-07-01 to 2021-09-30120,701USD92
2021-01-01 to 2021-09-30374,561USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-09-30503,002,741,330shares
At 2021-12-31488,499,407,996shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-09-30-49,379,068USD
At 2021-12-31-62,263,494USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-09-30177,385USD
At 2021-12-31201,518USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-4,715,455USD92
2022-01-01 to 2022-09-30-9,093,755USD273
2021-07-01 to 2021-09-30-2,032,470USD92
2021-01-01 to 2021-09-30-2,505,450USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30106,828USD92
2022-01-01 to 2022-09-30377,168USD273
2021-07-01 to 2021-09-30466,847USD92
2021-01-01 to 2021-09-30736,501USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2022-07-01 to 2022-09-308,881USD92
2022-01-01 to 2022-09-3045,515USD273
2021-07-01 to 2021-09-30-19,519USD92
2021-01-01 to 2021-09-30-50,435USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-01-01 to 2022-09-30611,250USD273
2021-01-01 to 2021-09-30170,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-3010,136USD273
2021-01-01 to 2021-09-3019,327USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-3010,979USD273
2021-01-01 to 2021-09-304,085USD273

Inspect the source

Entity
WORLD HEALTH ENERGY HOLDINGS, INC. / CIK 0000943535
Captured
2026-09-20T05:10:13.576Z
SEC response SHA-256
92f08c10292ee61a8402393503e39a04177155024d516f8fdc7961e83767f0ba

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000943535.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))